@article{harris2016the,
 abstract = {Objective:To describe the baseline clinical and functional characteristics of an international cohort of 193 patients with dysferlinopathy. Methods:The Clinical Outcome Study for dysferlinopathy (COS) is an international multicenter study of this disease, evaluating patients with genetically confirmed dysferlinopathy over 3 years. We present a cross-sectional analysis of 193 patients derived from their baseline clinical and functional assessments. Results:There is a high degree of variability in disease onset, pattern of weakness, and rate of progression. No factor, such as mutation class, pro...},
 author = {Mbbs Elizabeth Harris and C. Bladen and PhD Anna Mayhew and PT Meredith James and MSc Karen Bettinson and MBBChir Ursula Moore and PhD Fiona E. Smith and PhD Laura Rufibach and PhD Avital Cnaan and MD Diana X. Bharucha-Goebel and A. M. Blamire and MD Elena Bravver and MD Pierre G. Carlier and P. Day and Priya Md and P. Eagle and P. Pt and M. Harms and Md K Jones and Priya Md and MD Jerry R. Mendell and M. Mori-Yoshimura and MD Carmen Paradas and Priya Md and PhDHyunSunJeon Md and MD Emmanuelle Salort-Campana and MD Olivia Schreiber-Katz and MD Claudio Semplicini and MD Simone Spuler and Malfait F. The and John Walton Muscular Dystrophy Research Centre E.H and K. Bushby and MD Tanya Stojkovic and MD Volker Straub and MD PhD Shin ’ ich Takeda and MD Carolina Tesi Rocha and MD MA M.C. Walter},
 doi = {10.1212/NXG.0000000000000089},
 journal = {Neurology: Genetics},
 title = {The Clinical Outcome Study for dysferlinopathy},
 volume = {2},
 year = {2016}
}